In the last month, we at CDD have released six new Data Sets on our Public Access Page!
Three of these Data Sets are from TimTec, a chemical vendor we have collaborated with before. The first new TimTec library is their Diversity Set, a screening library of about 10,000 diverse compounds. Second is a set of OGlcNAc Transferase Inhibitor Analogs. Finally, TimTec’s ActiTarg-K Kinase modulators finish out the trio. For a more detailed description of these three sets, click here.
We have also added a set of nearly 2,000 compounds screened for anti-Malaria activity (3D7 and Dd2), provided by the Johns Hopkins Clinical Compound Library.
On the Tuberculosis front, CDD’s own Sean Ekins, PhD has released a set of thirty-two 1,3 benzothiazin-4-one compounds published by Markov et. al at the NM4TB consortia.
Finally, Robert Goldman of the Southern Research Institute has made available a set of compounds screened against Mtb H37Rv. This set of more than 200,000 compounds was collected by the Molecular Small Molecule Repository (MLSMR) in the spring of last year.
If you want to gain access to these new Data Sets, please register on our Public Access page.
This blog is authored by members of the CDD Vault community. CDD Vault is a hosted drug discovery informatics platform that securely manages both private and external biological and chemical data. It provides core functionality including chemical registration, structure activity relationship, chemical inventory, and electronic lab notebook capabilities!
CDD Vault: Drug Discovery Informatics your whole project team will embrace!
Translated with Google Translate